Use of catabolic enzymes for controlling the acquired immune def

Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Multienzyme complexes or mixtures of enzymes

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 9421, 424 946, 424 9465, 424580, 4241951, A61K 3762, A61K 3754, A61K 3578, A61K 3555

Patent

active

050027662

ABSTRACT:
The therapy approaches known so far for the treatment of the acquired immune deficiency syndrome (AIDS) and its precursors (LAS and ARC) and the secondary diseases related thereto such as opportunistic infections and malignant tumours are either directed against the proliferation of the virus in the body or against the pathogenic organisms of the opportunistic infections or they are selected from the known agents against malignant tumours. So far all therapies did not have any significant success.
The new use of catabolic enzymes for the therapy of AIDS and its precursors (LAS and ARC) is made available, with which completely unexpected successes can be achieved in the improvement of the condition of the patient.

REFERENCES:
patent: 4571336 (1986-02-01), Houck et al.
patent: 4591504 (1986-05-01), Ohnishi et al.
patent: 4826680 (1989-05-01), Jaeger

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Use of catabolic enzymes for controlling the acquired immune def does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of catabolic enzymes for controlling the acquired immune def, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of catabolic enzymes for controlling the acquired immune def will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-616137

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.